Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seqirus QIV versus active comparator QIV in children 6 to 59 months
2016-004753-33Phase 3
- Sponsor
- CSL Limited
- Start
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Afluria Quad and influenza virus quadrivalent inactivated vaccine in influenza (2 arms), sponsored by CSL Limited. Primary endpoint: Geometric mean titer ratio for each virus strain.
02
Drugs
Afluria Quadinfluenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2016-004753-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004753-33.